Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
LifeStance Health Group
LFST
LifeStance Health Group
Digital Advancements And Telehealth Will Expand Mental Health Access
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
04 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$10.00
45.6% undervalued
intrinsic discount
16 Aug
US$5.44
Loading
1Y
-6.4%
7D
19.0%
Author's Valuation
US$10.0
45.6% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$10.0
45.6% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-397m
2b
2019
2021
2023
2025
2027
2028
Revenue US$2.0b
Earnings US$204.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
13.89%
Healthcare Services revenue growth rate
0.27%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$204.73m
Earnings '28
x
24.26x
PE Ratio '28
=
US$4.97b
Market Cap '28
US$4.97b
Market Cap '28
/
408.51m
No. shares '28
=
US$12.16
Share Price '28
US$12.16
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$9.99
Fair Value '25